{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:25:00Z","timestamp":1792218300727,"version":"4.4.0"},"reference-count":95,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.17652","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T15:49:24Z","timestamp":1602172164000},"page":"e2017652","source":"Crossref","is-referenced-by-count":53,"title":["Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation"],"prefix":"10.1001","volume":"3","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Hematology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"},{"name":"The Pq Laboratory of Micro\/Nano BiomeDx, Department of Biomedical Engineering, Binghamton University \u2013 SUNY, Binghamton, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Fu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wan","sequence":"additional","affiliation":[{"name":"The Pq Laboratory of Micro\/Nano BiomeDx, Department of Biomedical Engineering, Binghamton University \u2013 SUNY, Binghamton, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"issue":"12","key":"zoi200635r1","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"zoi200635r2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s12032-009-9339-0","article-title":"Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials.","volume":"27","author":"Wang","year":"2010","journal-title":"Med Oncol"},{"issue":"2","key":"zoi200635r3","first-page":"381","article-title":"Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.","volume":"20","author":"Xu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"zoi200635r4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12879-015-0855-6","article-title":"Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.","volume":"15","author":"Bow","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"2","key":"zoi200635r5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis.","volume":"159","author":"Cipriani","year":"2013","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi200635r6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"zoi200635r7","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"10","key":"zoi200635r8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA.","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"zoi200635r9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1536867X1101100206","article-title":"Multivariate random-effects meta-regression: updates to mvmeta.","volume":"11","author":"White","year":"2011","journal-title":"The Stata Journal"},{"issue":"2","key":"zoi200635r10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi200635r11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies.","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"key":"zoi200635r12","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata.","volume":"39","author":"Shim","year":"2017","journal-title":"Epidemiol Health"},{"issue":"3","key":"zoi200635r13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews.","volume":"41","author":"Turner","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"11-12","key":"zoi200635r14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/myc.1993.36.issue-11-12","article-title":"Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies.","volume":"36","author":"Akiyama","year":"1993","journal-title":"Mycoses"},{"issue":"6","key":"zoi200635r15","first-page":"512","article-title":"Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.","volume":"80","author":"Annaloro","year":"1995","journal-title":"Haematologica"},{"issue":"6","key":"zoi200635r16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF01697981","article-title":"Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.","volume":"71","author":"Behre","year":"1995","journal-title":"Ann Hematol"},{"issue":"2","key":"zoi200635r17","first-page":"127","article-title":"Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation: results of a randomized placebo-controlled trial.","volume":"7","author":"Benhamou","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"zoi200635r18","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.","volume":"73","author":"Bodey","year":"1994","journal-title":"Cancer"},{"issue":"1","key":"zoi200635r19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/jac\/48.1.97","article-title":"Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.","volume":"48","author":"Boogaerts","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"1-2","key":"zoi200635r20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0954-6820.1978.tb08410.x","article-title":"Prophylactic treatment with miconazole in patients highly predisposed to fungal infection: a placebo-controlled double-blind study.","volume":"204","author":"Brincker","year":"1978","journal-title":"Acta Med Scand"},{"issue":"5","key":"zoi200635r21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1439-0507.1983.tb03203.x","article-title":"Prevention of mycosis in granulocytopenic patients with prophylactic ketoconazole treatment.","volume":"26","author":"Brincker","year":"1983","journal-title":"Mykosen"},{"issue":"3","key":"zoi200635r22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/TP.0b013e3182577485","article-title":"Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.","volume":"94","author":"Chaftari","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"zoi200635r23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jac\/33.2.309","article-title":"The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients.","volume":"33","author":"Chandrasekar","year":"1994","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"zoi200635r24","first-page":"71","article-title":"Itraconazole oral solution versus fluconazole syrup for prevention of invasive fungal infections in patients receiving hematopoietic stem cell transplantation: prospective, randomized, comparative clinical trial.","volume":"37","author":"Choi","year":"2005","journal-title":"Infect Chemother"},{"issue":"4","key":"zoi200635r25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia.","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi200635r26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0195-6701(84)90105-1","article-title":"Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.","volume":"5","author":"Donnelly","year":"1984","journal-title":"J Hosp Infect"},{"issue":"2","key":"zoi200635r27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00365855","article-title":"Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients: a prospective, randomized, single-center study.","volume":"3","author":"Egger","year":"1995","journal-title":"Support Care Cancer"},{"issue":"1","key":"zoi200635r28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF02026116","article-title":"Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients.","volume":"13","author":"Ellis","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"zoi200635r29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jinf.2018.03.015","article-title":"Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: a randomized study.","volume":"77","author":"Epstein","year":"2018","journal-title":"J Infect"},{"issue":"8","key":"zoi200635r30","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/archinte.1984.00350200054006","article-title":"Infection prophylaxis in acute leukemia: comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two.","volume":"144","author":"Estey","year":"1984","journal-title":"Arch Intern Med"},{"issue":"17","key":"zoi200635r31","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jama.2019.15702","article-title":"Effect of caspofungin vs fluconazole prophylaxis on invasive fungal disease among children and young adults with acute myeloid leukemia: a randomized clinical trial.","volume":"322","author":"Fisher","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"zoi200635r32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jac\/dki440","article-title":"An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.","volume":"57","author":"Glasmacher","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"13","key":"zoi200635r33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi200635r34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/archinte.1987.00370040092016","article-title":"Ketoconazole in the prevention of candidiasis in patients with cancer: a prospective, randomized, controlled, double-blind study.","volume":"147","author":"Hansen","year":"1987","journal-title":"Arch Intern Med"},{"issue":"7","key":"zoi200635r35","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1128\/AAC.44.7.1887-1893.2000","article-title":"Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.","volume":"44","author":"Harousseau","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"zoi200635r36","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/j.bbmt.2013.12.117","article-title":"Voriconazole vs itraconazole for antifungal prophylaxis in patients with GVHD: a randomized trial.","volume":"20","author":"Hayashi","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"zoi200635r37","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1128\/AAC.49.4.1331-1336.2005","article-title":"Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.","volume":"49","author":"Hiemenz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"zoi200635r38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12185-008-0196-y","article-title":"Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation.","volume":"88","author":"Hiramatsu","year":"2008","journal-title":"Int J Hematol"},{"issue":"10","key":"zoi200635r39","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.bbmt.2012.03.014","article-title":"Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.","volume":"18","author":"Huang","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"zoi200635r40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/jcp.52.5.376","article-title":"Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.","volume":"52","author":"Huijgens","year":"1999","journal-title":"J Clin Pathol"},{"issue":"2","key":"zoi200635r41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1532\/IJH97.06079","article-title":"The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.","volume":"85","author":"Ito","year":"2007","journal-title":"Int J Hematol"},{"issue":"1","key":"zoi200635r42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10156-002-0207-5","article-title":"Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia.","volume":"9","author":"Kaptan","year":"2003","journal-title":"J Infect Chemother"},{"issue":"2","key":"zoi200635r43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"zoi200635r44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<291::AID-CNCR13>3.0.CO;2-O","article-title":"Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study.","volume":"83","author":"Kern","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"zoi200635r45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajh.10234","article-title":"Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.","volume":"71","author":"Koh","year":"2002","journal-title":"Am J Hematol"},{"issue":"9","key":"zoi200635r46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-003-0666-5","article-title":"Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution.","volume":"82","author":"Lass-Fl\u00f6rl","year":"2003","journal-title":"Ann Hematol"},{"issue":"6","key":"zoi200635r47","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/46.6.1001","article-title":"Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients: the Canadian Fluconazole Study.","volume":"46","author":"Laverdi\u00e8re","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"zoi200635r49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"issue":"4","key":"zoi200635r50","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"issue":"2","key":"zoi200635r51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cncr.11094","article-title":"Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.","volume":"97","author":"Mattiuzzi","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"zoi200635r52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.50.1.143-147.2006","article-title":"Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies.","volume":"50","author":"Mattiuzzi","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"zoi200635r53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00520-009-0783-3","article-title":"Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.","volume":"19","author":"Mattiuzzi","year":"2011","journal-title":"Support Care Cancer"},{"issue":"2","key":"zoi200635r54","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","article-title":"Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial.","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi200635r55","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2141.1999.01465.x","article-title":"A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies.","volume":"105","author":"Morgenstern","year":"1999","journal-title":"Br J Haematol"},{"issue":"2","key":"zoi200635r56","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/313654","article-title":"A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.","volume":"30","author":"Nucci","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi200635r57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bmt.1705418","article-title":"A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.","volume":"38","author":"Oren","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"zoi200635r58","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1992.tb00945.x","article-title":"Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias.","volume":"231","author":"Palmblad","year":"1992","journal-title":"J Intern Med"},{"issue":"5","key":"zoi200635r59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jinf.2016.06.011","article-title":"Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.","volume":"73","author":"Park","year":"2016","journal-title":"J Infect"},{"issue":"8","key":"zoi200635r60","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mdl128","article-title":"Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial.","volume":"17","author":"Penack","year":"2006","journal-title":"Ann Oncol"},{"issue":"5","key":"zoi200635r61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","article-title":"Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients.","volume":"165","author":"Perfect","year":"1992","journal-title":"J Infect Dis"},{"issue":"6","key":"zoi200635r62","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/31.6.973","article-title":"Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia.","volume":"31","author":"Philpott-Howard","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"zoi200635r63","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi200635r64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(94)90345-X","article-title":"The prophylactic use of low-dose amphotericin B in bone marrow transplant patients.","volume":"97","author":"Riley","year":"1994","journal-title":"Am J Med"},{"issue":"2","key":"zoi200635r65","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/515128","article-title":"Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy.","volume":"28","author":"Rotstein","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"12","key":"zoi200635r66","first-page":"1692","article-title":"Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia in children undergoing chemotherapy and hematopoietic stem cell transplantation.","volume":"50","author":"Sawada","year":"2009","journal-title":"Rinsho Ketsueki"},{"issue":"4","key":"zoi200635r67","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/172.4.1035","article-title":"Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias.","volume":"172","author":"Schaffner","year":"1995","journal-title":"J Infect Dis"},{"issue":"11","key":"zoi200635r68","first-page":"3654","article-title":"Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial.","volume":"93","author":"Schwartz","year":"1999","journal-title":"Blood"},{"issue":"9","key":"zoi200635r69","doi-asserted-by":"crossref","first-page":"738","DOI":"10.5414\/CP201880","article-title":"Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.","volume":"51","author":"Shen","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"6","key":"zoi200635r70","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective, randomized, double-blind study.","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"issue":"6","key":"zoi200635r71","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"zoi200635r72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi200635r73","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi200635r74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jinf.2007.07.003","article-title":"A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).","volume":"55","author":"Vehreschild","year":"2007","journal-title":"J Infect"},{"issue":"5-6","key":"zoi200635r75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428199309067926","article-title":"Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy: a double blind, placebo controlled study.","volume":"11","author":"Vreugdenhil","year":"1993","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"zoi200635r76","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0002-9343(87)90949-1","article-title":"Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole.","volume":"83","author":"Wingard","year":"1987","journal-title":"Am J Med"},{"issue":"24","key":"zoi200635r77","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"issue":"7","key":"zoi200635r78","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized placebo-controlled, double-blind, multicenter trial.","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"issue":"9","key":"zoi200635r79","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients: a multicenter, randomized trial.","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi200635r80","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702233","article-title":"Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.","volume":"25","author":"Wolff","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"835","key":"zoi200635r81","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/pgmj.71.835.284","article-title":"Prophylactic use of fluconazole in neutropenic cancer patients.","volume":"71","author":"Yama\u00e7","year":"1995","journal-title":"Postgrad Med J"},{"issue":"8","key":"zoi200635r82","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0959-8049(99)00102-1","article-title":"A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia.","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"issue":"2","key":"zoi200635r83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).","volume":"97","author":"Mellinghoff","year":"2018","journal-title":"Ann Hematol"},{"issue":"11","key":"zoi200635r84","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2165\/00003495-200565110-00007","article-title":"Posaconazole.","volume":"65","author":"Keating","year":"2005","journal-title":"Drugs"},{"issue":"2","key":"zoi200635r85","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/phar.1533","article-title":"Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole.","volume":"35","author":"Guarascio","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"4","key":"zoi200635r86","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi200635r87","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America.","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi200635r88","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jcpt.12579","article-title":"A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.","volume":"42","author":"Leonart","year":"2017","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"zoi200635r89","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/AAC.01985-15","article-title":"Network meta-analysis and pharmacoeconomic evaluation of fluconazole, itraconazole, posaconazole, and voriconazole in invasive fungal infection prophylaxis.","volume":"60","author":"Zhao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"zoi200635r90","doi-asserted-by":"crossref","first-page":"e00355","DOI":"10.1128\/AAC.00355-18","article-title":"Primary fungal prophylaxis in hematological malignancy: a network meta-analysis of randomized controlled trials.","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"12b","key":"zoi200635r91","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/imj.12598","article-title":"Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.","volume":"44","author":"Blyth","year":"2014","journal-title":"Intern Med J"},{"issue":"4","key":"zoi200635r92","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01974614","article-title":"A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies.","volume":"13","author":"Ninane","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"zoi200635r93","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1503\/cmaj.081086","article-title":"Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses.","volume":"181","author":"Ioannidis","year":"2009","journal-title":"CMAJ"},{"issue":"10","key":"zoi200635r94","doi-asserted-by":"crossref","first-page":"666","DOI":"10.7326\/M15-2521","article-title":"Uncertainty in treatment rankings: reanalysis of network meta-analyses of randomized trials.","volume":"164","author":"Trinquart","year":"2016","journal-title":"Ann Intern Med"},{"key":"zoi200635r95","doi-asserted-by":"crossref","first-page":"f5195","DOI":"10.1136\/bmj.f5195","article-title":"The effects of excluding treatments from network meta-analyses: survey.","volume":"347","author":"Mills","year":"2013","journal-title":"BMJ"},{"key":"zoi200635r48","volume-title":"Micafungin as a Prophylactic Antifungal During Induction Phase of Chemotherapy for Pediatric Acute Lymphoblastic Leukemia","author":"Mahmoud","year":"2016"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2771516\/wang_2020_oi_200635_1601603706.72996.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T05:59:44Z","timestamp":1696831184000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2771516"}},"subtitle":["A Systematic Review and Network Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":95,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.17652","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}